Content

Resources

Why Compliance-Driven CDMOs Win Sponsor Contracts

31 March 2026

CRO News

Quantum BioPharma Selects Allucent as CRO for Phase 2 Lucid-MS Trial

31 March 2026

CDMO News

ImmuneOncia Therapeutics Signs Manufacturing Agreement with Lonza for Danburstotug

30 March 2026

CDMO News

Vetter Wins Finished Dose CDMO of the Year at 2026 Awards During DCAT Week

30 March 2026

CDMO News

OXB Wins Most Innovative Cell & Gene Therapy CDMO Award at 2026 CDMO Leadership Awards

30 March 2026

CDMO News

WuXi Biologics Wins ‘Biologics CDMO of the Year’ at 2026 CDMO Leadership Awards

30 March 2026

Podcast

Digital Twins in Claude: How BioPharma Can Build Forecast and Supply Models

29 March 2026

Expert Insight

Why AAV Programs Fail to Scale and What Academics Need to Do Differently

27 March 2026

CDMO News

Lonza Launches Media Development Lab in Singapore to Support Bioprocessing Scale-Up

27 March 2026

CDMO News

SHINE Technologies Signs Lu-177 Supply Agreement with C-Ray for China Market

27 March 2026